Chondroitinase ABC promotes axonal re-growth and behavior recovery in spinal cord injury

doi:10.1016/j.bbrc.2006.08.136

Biochemical and Biophysical Research Communications

Volume 349, Issue 3, 27 October 2006, Pages 963-968

https://doi.org/10.1016/j.bbrc.2006.08.136 Get rights and content

Abstract

In spinal cord injury, the injury could trigger some inhibitory signal cascades to promote chondroitin sulfate proteoglycans (CSPGs), the structures of scar tissues, formation. CSPGs could limit axonal regeneration mainly through the glycosaminoglycan (GAG) chain in the lesion site were suggested. We hypothesized that the digestion of CSPGs by chondroitinase ABC (ChABC) might decrease the inhibitory effects of limiting axonal re-growth after spinal cord injury. We compared the digesting products of CSPGs such as 2B6 by ChABC with the untreated control group and found no immunostaining of 2B6 in control group. The smaller size scars of ChABC-treatment were observed via CS-56, a type of CSPGs, 8 weeks after transection by immunohistochemistry. The inhibitory effects of CSPGs withdraw GAGs following ChABC-treatment would reduce, and immunopositive GAP-43 newly outgrown fibers were identified. In the animal trials, ChABC-treatment could improve motor function through BBB locomotor’s test and reduce limiting ability of scar tissues to promote axonal regeneration via changing the structure of CSPGs by immunohistochemistry with GAP-43.

Section snippets

Materials and methods

The insertion of catheter and infusion of chondroitinase ABC after T8 complete spinal cord transection. We will use the SD female rats, 250–300 g weight, and all surgery was done under inhalation anesthesia with isoflurane and above homoeothermic blanket for keeping body temperature about 37 °C. The skin over foramen magnum was prepared and a longitudinal midline incision was made for exposure of magnum and C1 lamina. The epidural space was created just above the C1 lamina and the catheter was

Results

Three different concentrations of chondroitinase ABC (ChABC, 1 U/ml, 5 U/ml) were applied to degradation of chondroitin sulfate proteoglycans (CSPG, a family of extracellular matrix, up-regulated following spinal cord injury) in complete spinal cord injury animal model. The complete transection with lifting up of both cord stumps at the T8 level was performed in female Sprague–Dawley rats (250–300 g) from National Yang-Ming University; and the hind limb locomotor’s function was evaluated every

Discussion

Inhibition of axonal growth after SCI is thought to play a significant role in preventing regeneration and functional recovery. Some CSPG core proteins, particularly neurocan, versican, brevican, and NG2, are highly up-regulated following CNS injury [7]. In addition, other inhibitory factors such as myelin-associated inhibitors NoGo [8], and myelin-associated glycoprotein, could block axonal re-growth [8]. The present studies suggested that removing these inhibitory factors could promote axons’

References (21)

R.J. Gilbert et al.
CS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension
Mol. Cell Neurosci.
(2005)
M. Rosen et al.
Quantitation of repetitive epitopes in glycosaminoglycans immobilized on hydrophobic membranes treated with cationic detergents
Anal. Biochem.
(2002)
A.T. Beggah et al.
Lesion-induced differential expression and cell association of Neurocan, Brevican, Versican V1 and V2 in the mouse dorsal root entry zone
Neuroscience
(2005)
R. Gupta et al.
Chronic nerve compression induces local demyelination and remyelination in a rat model of carpal tunnel syndrome
Exp. Neurol.
(2004)
J.F. Talbott et al.
Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes
Exp. Neurol.
(2005)
S. Petrini et al.
Human melanoma/NG2 chondroitin sulfate proteoglycan is expressed in the sarcolemma of postnatal human skeletal myofibers. Abnormal expression in merosin-negative and Duchenne muscular dystrophies
Mol. Cell Neurosci.
(2003)
K.E. Rhodes et al.
Inhibiting cell proliferation during formation of the glial scar: effects on axon regeneration in the CNS
Neuroscience
(2003)
T.A. Watkins et al.
Nerve regeneration: re-growth stumped by shared receptor
Curr. Biol.
(2002)
A. Sandvig et al.
Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration
Glia
(2004)
F. Matsui et al.
Proteoglycans and injury of the central nervous system
Congenit. Anom. (Kyoto)
(2004)

There are more references available in the full text version of this article.

Cited by (68)

Enzyme-immobilized nanoclay hydrogel simultaneously reduces inflammation and scar deposition to treat spinal cord injury
2024, Chemical Engineering Journal
Spinal cord injury (SCI) is a severely disabling pathological condition and always results in sensory and motor functions loss. After SCI, inflammation-mediated secondary tissue damage and subsequent formation of neuroglial scar suppress neuron survival and regeneration, therefore resulting in severe neurofunctional dysfunction. Although nanoclay biomaterials demonstrated useful immunomodulation feature in non-neuronal tissue, it is unclear if they can inhibit inflammation in SCI lesions and promote neurofunctional recovery. In this study, we immobilized chondroitinase ABC enzyme (ChABC), which can degrade chondroitin sulfate proteoglycans (CSPGs) of neuroglial scar, inside nanoclay (Laponite®, Lap) hydrogel through electrostatic interaction. The presented ChABC-immobilized Lap hydrogel (ChABC@Lap) exhibited shear-thinning properties and excellent injectability, allowing to locally deliver it into injured area through a non-invasive manner. Cell biological experiments and SCI rat model research revealed that both pure Lap (without ChABC) and ChABC@Lap hydrogels significantly reduced pro-inflammatory macrophage marker (iNOS) intensity. Importantly, compared with Lap hydrogel, ChABC@Lap hydrogel significantly decreased GFAP and CS-56 marked scar deposition, increased Tuj-1⁺ neurons regeneration, and promoted NF200⁺ neurons survival, thereby improving SCI rat of electrophysiological characteristics and motor function. In summary, the designed enzyme-immobilized nanoclay hydrogel offers a promising strategy for SCI therapy through modulating simultaneously inflammation and glial scar deposition.
Physical and biological engineering of polymer scaffolds to potentiate repair of spinal cord injury
2021, Materials and Design
Although the mortality rates of patients suffering from spinal cord injury (SCI) have decreased as the modalities of clinical therapy have been improved, the recovery of motor and sensory functions remains a challenge, ultimately leading to paraplegia or quadriplegia. Recently, neural tissue engineering scaffolds with appropriate physical and biological functions have been extensively developed to promote nerve regeneration and improve motor and sensory functions during SCI therapy. In this work, we summarized the physical support and bioelectrical signal conduction of polymer scaffolds for SCI repair from the aspects of biocompatibility, biodegradation, internal structure, mechanical performance, and conductivity. In addition, the biological functions of the polymer scaffolds were reviewed for the reversal of adverse pathophysiological factors to improve the microenvironments of the injured site and promote endogenous neurogenesis during SCI therapy. Moreover, the future development of these engineered scaffolds for potential clinical applications was predicted.
Self-assembling peptide hydrogels for the stabilization and sustained release of active Chondroitinase ABC in vitro and in spinal cord injuries
2021, Journal of Controlled Release
Citation Excerpt :
groups (Fig. 6m, n). Our results confirmed the significant role of Chondroitinase ABC in favoring functional recovery, axonal sprouting and axonal regrowth in injured spinal cords [71,72] [73–75]. On the other hand, our innovative SAP-based delivery system for ChABC further boosted our previous findings in terms of both Chondroitinase ABC activity and delivery in vivo for neuro-regenerative therapies [22].
Activated microglia/macrophages infiltration, astrocyte migration, and increased production of inhibitory chondroitin sulfate proteoglycans (CSPGs) are standard harmful events taking place after the spinal cord injuries (SCI). The gliotic scar, viz. the outcome of chronic SCI, constitutes a long-lasting physical and chemical barrier to axonal regrowth. In the past two decades, various research groups targeted the hostile host microenvironments of the gliotic scar at the injury site. To this purpose, biomaterial scaffolds demonstrate to provide a promising potential for nervous cell restoration. We here focused our efforts on two self-assembling peptides (SAPs), featuring different self-assembled nanostructures, and on different methods of drug loading to exploit the neuroregenerative potential of Chondroitinase ABC (ChABC), a thermolabile pro-plastic agent attenuating the inhibitory action of CSPGs. Enzymatic activity of ChABC (usually lasting less than 72 hours in vitro) released from SAPs was remarkably detected up to 42 days in vitro. ChABC was continuously released in vitro from a few days to 42 days as well. Also, injections of ChABC loaded SAP hydrogels favored host neural regeneration and behavioral recovery in chronic SCI in rats. Hence, SAP hydrogels showed great promise for the delivery of Chondroitinase ABC in future therapies targeting chronic SCI.
Enhancing myelin repair in experimental model of multiple sclerosis using immobilized chondroitinase ABC I on porous silicon nanoparticles
2020, International Journal of Biological Macromolecules
Removal of chondroitin sulfate proteoglycans (CSPGs) with chondroitinase ABC I (ChABC) facilitates axonal plasticity, axonal regeneration and remyelination, following injury to the central nervous system (CNS). However, the ChABC rapidly undergoes thermal inactivity and needs to be injected repeatedly. Here this limitation was overcame by immobilizing the ChABC on porous silicon (PSi) nanoparticles (ChABC@PSi). The efficacy of immobilized ChABC on CSPGs level and the demyelination insult was assessed in mice corpora callosa demyelinated by 6 weeks cuprizone (CPZ) feeding. ChABC@PSi was able to reduce the amount of CSPGs two weeks after animals treatment. CSPGs digestion by ChABC@PSi reduced the extent of demyelinated area as well as the astrogliosis. Furthermore, ChABC@PSi treatment increased the number of newly generated oligodendrocyte lineage cells which imply for enhanced myelin repair. Our results showed that effective CSPGs digestion by ChABC@PSi enhanced remyelination in CPZ model. Accordingly, ChABC@PSi may have a great potential to be used for treatment of diseases like multiple sclerosis and spinal cord injury by promoting the regeneration of damaged nerves.
Histological correlates of hippocampal magnetization transfer images in drug-resistant temporal lobe epilepsy patients
2020, NeuroImage: Clinical
Temporal lobe epilepsy patients (TLE) often present with hippocampal atrophy, increased T2 relaxation, and reduced magnetization transfer ratio (MTR) in magnetic resonance images (MRI). The histological correlates of the reduced hippocampal MTR are so far unknown. Since MTR is dependent on the tissue’s macromolecules, our aim was to evaluate the correlations between cellular populations, extracellular matrix molecules and the MTR in TLE patients.
Patients with TLE (n = 26) and voluntaries (=20) were scanned in a 3 Tesla MRI scanner, and MTR images were calculated from 3DT1 sequences with magnetization pulse on resonance. Immunohistochemistry for neurons, reactive astrocytes, activated microglia, and extracellular matrix chondroitin sulfate were performed in formalin fixed, paraffin embedded tissues of TLE and autopsy controls (n = 10). Results were considered significant with adjusted p < 0.05.
Compared to the respective controls, TLE patients had reduced hippocampal MTR, increased reactive astrocytes and activated microglia, increased extracellular chondroitin sulfate, and reduced neuron density, compares to controls. MTR correlated positively with neuron density in CA3 and with chondroitin sulfate in CA3 and CA1. Multiple linear regressions reinforced the correlations between chondroitin sulfate and MTR.
Our data indicate that extracellular matrix molecules are the most significant histological correlates of magnetization transfer ratio in the hippocampus of TLE patients.
Crosstalk between glia, extracellular matrix and neurons
2018, Brain Research Bulletin
Citation Excerpt :
Transgenic mice expressing ChABC in astrocytes confirm a local efficacy for reduced CSPG expression to enhance axonal growth after injury (Cafferty et al., 2007). Intrathecal injection of ChABC after spinal cord injury upregulates regeneration-associated proteins, promote regeneration of sensory projections and corticospinal tract axons and behavior recovery (Bradbury et al., 2002; Huang et al., 2006). Mutant mice deficient in CS N-acetylgalactosaminyltransferease-1, necessary for CS synthesis, show complete functional recovery after spinal cord injury (Takeuchi et al., 2013).
Extracellular matrix (ECM) molecules in the central nervous system form highly organized ECM structures around cell somata, axon initial segments, and synapses and play prominent roles in early development by guiding cell migration, neurite outgrowth and synaptogenesis, and by regulating closure of the critical period of development, synaptic plasticity and stability, cognitive flexibility, and axonal regeneration in adults. Major components of neural ECM, including chondroitin sulfate proteoglycans (CSPGs), tenascin-R and hyaluronic acid, are synthesized by both neurons and glial cells. The expression of these molecules is dynamically regulated during brain development in physiological conditions, shaping both neuronal and glial functions through multitude of molecular mechanisms. Upregulation of particular CSPGs and other ECM molecules, in particular by reactive astrocytes, after CNS injuries, during aging, neuroinflammation, and neurodegeneration on the one hand results in formation of growth-impermissive environment and impaired synaptic plasticity. On the other hand, ECM appeared to have a neuroprotective effect, at least in the form of perineuronal nets. CSPGs-degrading matrix metalloproteinases (MMPs) and several members of the disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) family of proteases are secreted by neurons and glia and may drive neural ECM remodeling in physiological conditions as well as after brain injury and other brain disorders. Thus, targeting expression of specific ECM molecules, associated glycans and degrading enzymes may lead to development of new therapeutic strategies promoting regeneration and synaptic plasticity.

View all citing articles on Scopus

View full text

Chondroitinase ABC promotes axonal re-growth and behavior recovery in spinal cord injury

Abstract

Section snippets

Materials and methods

Results

Discussion

Mol. Cell Neurosci.

Anal. Biochem.

Neuroscience

Exp. Neurol.

Exp. Neurol.

Mol. Cell Neurosci.

Neuroscience

Curr. Biol.

Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration

Glia

Proteoglycans and injury of the central nervous system

Congenit. Anom. (Kyoto)